Pathophysiological mechanisms of statin‐associated myopathies: possible role of the ubiquitin‐proteasome system
Background Statins are the cornerstone of pharmacotherapy for atherosclerotic cardiovascular disease. While these drugs are generally safe, treatment adherence is not optimal in a considerable proportion of patients because of the adverse effects on skeletal muscles in the forms of myopathy, myalgia...
Saved in:
Main Authors: | Amirhossein Sahebkar (Author), Arrigo F.G. Cicero (Author), Paolo Di Giosia (Author), Irene Pomilio (Author), Cosimo Andrea Stamerra (Author), Paolo Giorgini (Author), Claudio Ferri (Author), Stephan vonHaehling (Author), Maciej Banach (Author), Tannaz Jamialahmadi (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of statins on mitochondrial pathways
by: Hamid Mollazadeh, et al.
Published: (2021) -
Anderson-Fabry Disease: From Endothelial Dysfunction to Emerging Therapies
by: Cosimo A. Stamerra, et al.
Published: (2021) -
Ubiquitin Proteasome System Current Insights into Mechanism Cellular Regulation and Disease
Published: (2019) -
Multi-Step Ubiquitin Decoding Mechanism for Proteasomal Degradation
by: Hikaru Tsuchiya, et al.
Published: (2020) -
Statin-Induced Myopathy
by: D. A. Sychev, et al.
Published: (2023)